IgA and the intestinal microbiota: the importance of being specific.

Pabst O, Slack E. · 2020

Read IgA and the intestinal microbiota: the importance of being specific. by Pabst O, Slack E. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6914667.txt.

Introduction

Pabst and Slack review secretory IgA, the chief antibody of the gut. Their review appeared in Mucosal Immunology. IgA is made in vast amounts each day. Yet experts still dispute what it does. Some cite the mild effects of IgA loss. Others stress its abundance and long history.

The pair revisit old disputes in IgA biology. They start with antigen specificity in the gut. They then set out clear terms for induction and function. Next they map the cell and molecular pathways that shape IgA. They also explain how IgA acts on microbes. On that basis, they propose how IgA helps build and keep helpful links with gut microbes.

Catalog record

CREATORPabst O, Slack E.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE66 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6914667

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

IgA and the intestinal microbiota: the importance of being specific By Oliver Pabst, Emma Slack Published in: Mucosal Immunology DOI: 10.1038/s41385-019-0227-4 ABSTRACT Secretory IgA has long been a divisive molecule. Some immunologists point to the mild phenotype of IgA deficiency to justify ignoring it, while some consider its abundance and evolutionary history as grounds for its importance. Further, there is extensive and growing disagreement over the relative importance of affinity-matured, T cell-dependent IgA vs. “natural” and T cell-independent IgA in both microbiota and infection control. As with all good arguments, there is good data supporting different opinions. Here we revisit longstanding questions in IgA biology. We start the discussion from the question of intestinal IgA antigen specificity and critical definitions regarding IgA induction, specificity, and function. These definitions must then be tessellated with the cellular and molecular pathways shaping IgA responses, and the mechanisms by which IgA functions. On this basis we propose how IgA may contribute to the establishment and maintenance of beneficial interactions with the microbiota. INTRODUCTION While scientific progress is rarely straightforward, IgA’s Odyssey seems particular confusing. IgA is the most abundantly produced antibody isotype but was the last isotype to be discovered. Research on IgA biology has dominated the emerging field of mucosal immunology and today we experience an exciting increase in the number of high impact studies on IgA. Nonetheless, we are lacking a comprehensive picture. Extensive work has been performed to study pathways of IgA generation and IgA memory but experts in the field barely agree on the relevance of IgA inductive sites and mechanisms.1,2 Counting ourselves as IgA supporters, we suggest that much of the confusion in the field might come from linguistic and biological oversimplifications. Aiming to avoid such inaccuracies, in this review, we will singly discuss new aspects in intestinal secretory IgA (SIgA) biology. We will base our discussion on critical definitions in IgA biology (see also Box 1) and focus on the interaction between SIgA and the intestinal microbiota. For an overview of IgA inductive compartment and class switch recombination please refer to Box 2 ‘Fast facts on SIgA’ and references therein. We emphasize that concepts in intestinal SIgA biology discussed here should not be applied lightheartedly to other mucosal tissues such as lung, eye, and urogenital tract or monomeric IgA predominantly present in serum. IgA shares the archetypical structure of other human and rodent antibody isotypes and is composed of Fab fragments and an Fc region each consisting of several Ig domains (Fig. 1a). However, unlike IgG and IgA in serum, in the human and murine gut, IgA is produced as polymeric IgA (pIgA), foremost as dimeric IgA. The dimeric form of IgA consists of an antibody dimer with two Ig monomers linked tail-to-tail through extensions of the terminal Ig domain of their Fc portion and a protein called joining (J) chain.3 Expression of polymeric IgA linked by a J chain is a distinguishing feature of mucosal plasma cells and distinguishes them from plasma cells in many other compartments such as spleen and bone marrow. Thus, the structure of intestinal pIgA is fundamentally different from the prevailing monomeric form of IgA present in human plasma.Fig. 1Secretory IgA is formed by the combined function of plasma cells producing multimeric IgA and epithelial cells expressing pIgR a Schematic diagrams illustrating the structure of human dimeric IgA1, human dimeric IgA2, human secretory IgA1, and the free secretory component (SC, which is a cleavage product of pIgR). Both, human IgA1 and IgA2 show the canonical antibody structure of two heavy and two light chains building Fab and Fc portions of the antibody. Human IgA1 is characterized by an extended hinge region linking the Fab and Fc part. In dimeric IgA, two antibody monomers are covalently bound through disulfide bonds to the J chain. Secretory component covalently bound to IgA differs in its conformation from free SC. Consequently, free SC and bound SC might have different microbiota binding capacity. b Transcytosis of pIgR/dIgA complexes results from initial recognition binding, conformational changes, and final binding before the complex becomes transcytosed. Following transcytosis, free SC, and SIgA are released into the gut lumen (here depicted for human IgA1). Illustrations adapted from refs.4,68 The polymeric structure of IgA is a prerequisite for its active transport across mucosal surfaces and secretion. This process is carried out by the polymeric Ig receptor (pIgR). However pIgR does not only transport multimeric IgA but contributes the secretory component that is covalently bound to the antibody portion and constitutes an integral part of the SIgA complex (Fig. 1). Thus, effectively SIgA is a chimeric molecule generated by the combined activity of both plasma cells and pIgR-expressing (mostly epithelial) cells. Consistently, production and secretion of SIgA is not only determined by rates of antibody production by plasma cells but additionally influenced by pIgR expression and activity. Human pIgR is a glycosylated transmembrane protein consisting of five Ig domains forming the pIgR ectodomain also referred to as secretory component (SC), a short transmembrane domain, and an intracellular domain.3 During its biosynthesis, pIgR is delivered to the basolateral side of epithelial cells where it binds pIgA (as well as polymeric IgM, not discussed here in more detail). Initial binding is conferred by the first Ig domain, followed by conformational changes in the molecule that further enhance stability of the complex and precede formation of a covalent bond between pIgA and pIgR.4 The SIgA complex is transported to the apical side and becomes cleaved to release the mature SIgA. The heavily N-glycosylated SC part of SIgA protects the complex from proteolysis: an essential contribution to its function in the digestive tract. However, free SC is also known to directly interact with intestinal bacteria5 and one might speculate that SC as part of the SIgA complex also might confer microbiota binding capacities. Thus, when discussing functions of SIgA, besides the plasma cell produced Fab/Fc portion and J chain, properties of the SC part contributed by epithelial cells have to be considered (Fig. 1). The pIgR is expressed by various secretory epithelial cells, including those lining the gastrointestinal tract and indeed local production of pIgA by intestinal plasma cells and transport across the gut epithelium contributes most to overall intestinal SIgA production/secretion. Yet, interesting complementation to intestinal SIgA production comes from expression of pIgR in mammary glands that confer transport of SIgA into milk,6 and expression in the liver that enables SIgA transport into bile.7 While the former pathway is only relevant to passive IgA transfer into very young mammals via milk, the latter pathway, SIgA secretion into bile and thereby the small intestine, also operates in adults. In rodents, polymeric IgA is transported from circulation across pIgR-expressing hepatocytes to the bile canalicular membrane and eventually into bile7 enabling the clearance of IgA bound antigen from circulation. In humans, expression of pIgR is restricted to biliary epithelial cells and concentrations of SIgA in bile are lower as compared with rodents. Nonetheless, also in humans IgA is transported into bile and plasma cells producing microbiota directed IgA are present in the liver.8 Thus both, SIgA in bile and milk, might create important sources of SIgA that meet particular needs locally in the proximal small intestine and temporally during early

Read the complete text